Company intelligence / Profile preview

SIA Health

Chicago, Illinois, USA

Ownership: Private
Employees: ~25
Development stage: Other

Overview

Surgical Innovation Associates (SIA) is a medical technology company that develops and commercializes bioabsorbable scaffolds for soft tissue repair and reconstruction. The company's flagship product, DuraSorb, is a monofilament mesh designed to provide mechanical support during the critical healing phase before being completely absorbed by the body. SIA focuses on improving clinical outcomes and reducing complications in plastic and reconstructive surgery, particularly in breast reconstruction. In December 2022, the company was acquired by Integra LifeSciences to enhance its global regenerative medicine portfolio.

Therapeutic areas: Women's HealthOther
Modalities: DeviceBioabsorbable polymer
Industry: Surgical Medical Devices

Beyond the preview

Go deeper on SIA Health.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on SIA Health.

Explore the full profile